Manufacturing output to moderate in 2H17

Semiconductor segment, however, will remain robust.

After slowing down to a 5% growth in May, Singapore's manufacturing production is expected to moderate further in 2H17.

According to RHB, however, this could be undermined by a fading low base effect. Also, the semiconductor production is set to grow at a softer, albeit still robust pace. This is supported by inventory building ahead of the new Apple iPhone launch.

More so, the pharmaceutical output is envisaged to remain weak, as a handful of best-selling drugs have patents expiring this year.

"Once a drug loses patent protection, its sales could drop by a staggering 90% average amid competition from lower-cost alternatives," RHB said.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia